|
|
| HLC |
| |
|
| Modalities | Yes | No | p-value |
| BMI |
|
|
|
|
|
| Normal | 31 (10.9%) | 110 (38.7%) | <0.01 |
|
| Pre-obesity | 37 (13%) | 46 (16.2%) | |
|
| Obesity | 13 (4.6%) | 20 (7.1%) | |
|
| Underweight | 12 (4.2%) | 15 (5.3%) | |
| Past treated tuberculosis |
|
|
|
|
|
| No | 91 (32%) | 168 (59.2%) | <0.01 |
|
| Yes | 2 (0.7%) | 23 (8.1%) |
|
| History of HAART regimen substitution |
|
|
|
|
|
| No | 30 (10.6%) | 92 (32.4%) | 0.011 |
|
| Yes | 63 (22.2%) | 99 (34.8%) | |
| HCT |
|
|
|
|
|
| No | 15 (5.3%) | 182 (64.1%) | <0.001 |
|
| Yes | 78 (27.5%) | 9 (3.1%) | |
| Ratio CT/HDL-c ≥ 5 |
|
|
|
|
|
| No | 58 (20.4%) | 184 (64.8%) | <0.001 |
|
| Yes | 35 (12.3%) | 7 (2.5%) | |